A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in Taiwan
Journal article published in 2017 by
Pei-Chien Tsai,
Ta-Wei Liu,
Meng-Hsuan Hsieh,
Ming-Lun Yeh,
Po-Cheng Liang,
Yi-Hung Lin,
Ching-I. Huang,
Chung-Feng Huang,
Ming-Yen Hsieh,
Nai-Jen Hou,
Zu-Yau Lin,
Shinn-Cherng Chen,
Jee-Fu Huang 
,
Chia-Yen Dai,
Wan-Long Chuang
and other authors.
,
Chia-Yen Dai,
Wan-Long Chuang
and other authors.
